# US 2017/0226139 A1 · Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0226139 A1
- Document ID: US20170226139A1
- Status: Published application
- Kind: A1
- Application number: 15/429,972
- Filed: 2017-02-10
- Published: 2017-08-10
- Earliest claimed: 2013-12-30
- Assignees: RxBio, Inc.
- Applicants: RxBio Inc.
- Inventors: Rama Krishna Reddy Singidi; Veeresh Gududuru; Mahmoud Mirmehrabi; Karin Emmons Thompson; Gabor Jozsef Tigyi; Charles Ryan Yates; Jurriaan Strobos
- Web page: https://patentgrep.com/patent/US20170226139A1

## CPC

- C07F 9/062: {Organo-phosphoranes without P-C bonds}
- C07C 229/26: having more than one amino group bound to the carbon skeleton, e.g. lysine
- C07F 9/203: with unsaturated acyclic alcohols
- C07F 9/205: with hydroxyaryl compounds
- C07F 9/206: containing P-halide groups
- C07F 9/2408: {of hydroxyalkyl compounds}
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Here provided are a salt of Z)—O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate with an L-lysine addition in crystalline form and methods of making and using the same.

## Claims

### Claim 1

A method for producing Rx100.L-lysine crystalline salts, comprising the steps of:
a. mixing Rx100 free acid with L-lysine; and
b. allowing the Rx100.L-Lysine salt to form in the presence of a suitable amount of a solvent.

### Claim 2 (depends on 1)

The method of claim 1, wherein L-lysine base is used at molar equivalents of 1.0 of the free acid.

### Claim 3 (depends on 1)

The method of claim 1, wherein L-lysine base is used at molar equivalents of 1.5 of the free acid.

### Claim 4 (depends on 1)

The method of claim 1, wherein L-lysine base is used at molar equivalents of 2.0 of the free acid.

### Claim 5 (depends on 1)

The method of claim 1, wherein L-lysine base is used at molar equivalents of 3.0 of the free acid.

### Claim 6 (depends on 1)

The method of claim 1, wherein the solvent is selected from the group consisting of methanol, Isopropyl alcohol (IPA), IPA:water (95:5 vol), tert-Butyl methyl ether (tBME), Ethyl acetate, IPA:water (1:1 vol), Diethyl ether, tetrahydrofuran, or a combination thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein the amount of solvent is 3 to 20 volumes of the Rx100.FA, preferably between 5-8 volumes.

### Claim 8 (depends on 1)

The method of claim 1, wherein the solvent is a mixture of methanol and water.

### Claim 9 (depends on 1)

The method of claim 1, wherein the solvent is a mixture of methanol, water, and IPAc.

### Claim 10 (depends on 9)

The method of claim 9, the mixture of methanol, water, and IPAc is at a weight ratio of 10:2:1.5.

### Claim 11 (depends on 1)

The method of claim 1, wherein the solvent is a mixture of methanol and 10-50% IPAc, preferably 20-50% IPAc.

### Claim 12 (depends on 1)

The method of claim 1, wherein the solvent is methanol alone.

### Claim 13 (depends on 12)

The method of claim 12, wherein the methanol is about 5 to 20 molar equivalent, preferably about 12 molar equivalent of Rx100 free acid.

### Claim 14 (depends on 1)

The method of claim 1, wherein the crystalline salts form in the solvent in which the Rx100. free acid and L-lysine base are mixed.

### Claim 15 (depends on 1)

The method of claim 1, further comprising the steps of depleting the solvent in which the Rx100.FA and L-lysine base are mixed is first depleted after the mixing step (a) is carried out, and adding a fresh solvent in the dried material so that crystalline salts form in the fresh solvent.

### Claim 16 (depends on 15)

The method of claim 15, wherein the fresh solvent is the same solvent as that in which the Rx100.FA and L-lysine base are mixed.

### Claim 17 (depends on 15)

The method of claim 15, wherein the fresh solvent is a different solvent from that in which the Rx100.FA and L-lysine base are mixed.

### Claim 18 (depends on 1)

The method of claim 1 further comprising the step of: filtering, washing and drying the Rx100.L-Lysine crystalline salt.

### Claim 19 (depends on 18)

The method of claim 18, wherein filtering is carried out by using a filtering membrane.

### Claim 20

A method for producing a (Z)—O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate free acid, comprising the steps of:
a. mixing a thiophosphoryl chloride (PSCl3) with oleyl alcohol in a reaction that also include a base and a solvent to obtain an intermediate O—(Z)-oleyl dichloridothiophosphate; and
b. allowing a hydrolysis reaction of the intermediate O—(Z)-oleyl dichloridothiophosphate to form (Z)—O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate free acid.
